-+ 0.00%
-+ 0.00%
-+ 0.00%

BioLine Rx Q2 Sales $294.000K Miss $500.000K Estimate

Benzinga·08/31/2026 11:01:45
Listen to the news
BioLine Rx (NASDAQ:BLRX) reported quarterly sales of $294.000 thousand which missed the analyst consensus estimate of $500.000 thousand by 41.20 percent. This is a 3.29 percent decrease over sales of $304.000 thousand the same period last year.